“Although a typical course of Synagis is usually...

“Although a typical course of Synagis is usually five doses, given the severity of the current RSV season and the potential for it to last longer than the usual six months, it is imperative we protect our most vulnerable pediatric population.”   —Nishita Hira, Pharm.D., CSP, clinical program manager at AllianceRx Walgreens, spoke with Radar on Specialty Pharmacy about the increased severity in this year’s RSV season, and how specialty pharmacies manage Sobi’s Synagis, the only FDA-approved drug for RSV prevention.

 

Subscribers may read the Radar on Specialty Pharmacy article in which this quote appeared online. Learn more about subscribing to AIS Health's publications.